The doctor uses the DBS clinician programming device to adjust the settings on the implanted neurostimulator. [Image courtesy of Medtronic]
Medtronic DBS therapy for epilepsy
Medtronic Brain Modulation
Medtronic deep brain stimulation for epilepsy is a therapy that is designed for people who have an average of six or more seizures per month over a three month period. It is designated for use in patients 18 years and older who have been diagnosed with epilepsy characterized by partial-onset seizures, with and without secondary generalization and are refractory to three or more antiepileptic medications.
The stimulation has been shown to reduce the frequency of seizures in adults with medically refractory partial-onset epilepsy. It has reduced the most severe seizures, complex partial seizures and the incidence of epilepsy-related injury. People who have used Medtronic deep brain stimulation have also reported improved long-term quality of life.
Medtronic deep brain stimulation for epilepsy works by targeting the anterior nucleus of the thalamus, which is the part of the brain that is involved with producing seizures. The leads are implanted bilaterally in the anterior nucleus of the thalamus and provide controlled electrical stimulation to modulate the network, according to the company.
